article thumbnail

Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

Drug Patent Watch

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020.

97
article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Themes of The World Pharmacists Day 2010-2020

Pharma Mirror

World Pharmacist Day is celebrated on 25th September every year since 2010 on the day FIP (International Pharmaceutical Federation) started their journey. The post The Themes of The World Pharmacists Day 2010-2020 appeared first on Pharma Mirror Magazine.

97
article thumbnail

Air quality improvements belie rising racial and ethnic disparities in pollutant-related deaths, study finds

STAT

Researchers found an overall drop from 2010 and 2019 in death and disease linked to nitrogen dioxide (NO2), an air pollutant produced from fossil fuel burning, and fine particulate matter (PM2.5) Deaths attributable to PM2.5

286
286
article thumbnail

Opinion: Eliminate the waiting period for sterilization covered by Medicaid

STAT

From 1919 to 1952, more than 20,000 nonconsensual sterilizations took place in that state; the law was not repealed until 1979 in state hospitals and, frighteningly, was still in effect in state prisons until 2010. Read the rest…

Hospitals 270
article thumbnail

Here’s why we’re not prepared for the next wave of biotech innovation

STAT

It was 2010. I was standing by the Long Island Sound in Sachem’s Head, Conn., in the shadow of an 11-foot-tall granite Stonehenge replica built by Jonathan Rothberg, a biotech entrepreneur, as he talked up his newest gadget, a tabletop DNA sequencer. Read the rest…

article thumbnail

STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud

STAT

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

293
293